Jiangsu Nhwa Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Nhwa Pharmaceutical Company Limited with three other
companies in this sector in China:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.38 billion Chinese Renmimbi [US$200.04 million]
of which 62%
was Pharmaceutical Business Trade),
China Pioneer Pharma Holdings Ltd
(1.46 billion Chinese Renmimbi [US$211.70 million]
of which 59%
was Products sold via the provision of co-pr), and
Zhejiang Zhenyuan Co., Ltd.
(2.16 billion Chinese Renmimbi [US$313.36 million]
of which 78%
was Medicine Wholesales).
During the year ended December of 2015, sales at
Jiangsu Nhwa Pharmaceutical Company Limited were 2.77 billion Chinese Renmimbi (US$400.75 million).
increase of 10.6%
versus 2014, when the company's sales were 2.50 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Nhwa Pharmaceutical Company Limited
(and since 2010, sales have increased a total of 113%).
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
181.1% in 2015, from
13.88 million Chinese Renmimbi to 39.02 million Chinese Renmimbi.